We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Advanced Medical Solutions Group Plc | LSE:AMS | London | Ordinary Share | GB0004536594 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.80 | -0.43% | 185.80 | 185.60 | 187.00 | 188.80 | 185.20 | 187.40 | 272,263 | 16:35:08 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Plastics,resins,elastomers | 126.21M | 15.89M | 0.0732 | 25.44 | 404.45M |
TIDMAMS TIDMAV.
RNS Number : 6074T
Advanced Medical Solutions Grp PLC
30 March 2016
For filings with the FCA include the annex For filings with issuer exclude the annex TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) ------------------------------------------------------------------------------------------------------- 1. Identity of the issuer or Advanced Medical Solutions the underlying issuer Group plc of existing shares to which voting rights are attached: (ii) ----------------------------------------------------------------- ------------------------------------ 2 Reason for the notification (please tick the appropriate box or boxes): ------------------------------------------------------------------------------------------------------- An acquisition or disposal of voting rights -------------------------------------------------------------------- --------------------------------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached -------------------------------------------------------------------- --------------------------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments -------------------------------------------------------------------- --------------------------------- An event changing the breakdown of voting rights -------------------------------------------------------------------- --------------------------------- Other (please specify): ----------------------------------------------------------- ------- --------------------------------- 3. Full name of person(s) Aviva plc & its subsidiaries subject to the notification obligation: (iii) ------------------------------------------------------------- ---------------------------------------- 4. Full name of shareholder(s) Registered Holder: (if different from 3.):(iv) BNY Norwich Union Nominees Limited 447,817* Chase (GA Group) Nominees Limited 6,002,379* Chase Nominees Limited 197,728* Available on Request 43,500* * denotes direct interest ------------------------------------------------------------- ---------------------------------------- 5. Date of the transaction 29 March 2016 and date on which the threshold is crossed or reached: (v) ------------------------------------------------------------- ---------------------------------------- 6. Date on which issuer 30 March 2016 notified: ------------------------------------------------------------- ---------------------------------------- 7. Threshold(s) that is/are 3% to 4% Change at Direct crossed or Interest Level (Box 8A + 8B) reached: (vi, vii) ------------------------------------------------------------- ---------------------------------------- 8. Notified details: -------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) -------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE --------------- --------------------------- ---------------------------------------------------------------- Number Number Number Number of voting % of voting of of of shares rights rights (x) Shares Voting Rights --------------- -------------- ----------- ----------- -------------------------- ----------------------- Direct Direct Indirect Direct Indirect (xi) (xii) --------------- -------------- ----------- ----------- ---------- -------------- ------- -------------- Ordinary Shares Not Not GB0004536594 8,274,844* 8,274,844* 6,691,424 6,691,424 Disclosable 3.20% Disclosable -------------- ----------- ----------- ---------- -------------- ------- -------------- * Includes Right to Recall Loaned Shares (1,829,118) -------------------------------------------------------------------------------------------------------------- B: Qualifying Financial Instruments -------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction -------------------------------------------------------------------------------------------------------------- Type of Expiration Exercise/ Number of voting % of voting financial date Conversion rights that rights instrument (xiii) Period (xiv) may be acquired if the instrument is exercised/ converted. --------------- -------------- ------------------------ -------------------------- ----------------------- RIGHT TO 1,769,027* RECALL LOANED SHARES N/A N/A *Direct Interest 0.85% --------------- -------------- ------------------------ -------------------------- ----------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ----------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ----------------------------------------------------------------------------------------------- Type of financial Exercise Expiration Exercise/ Number of voting % of voting instrument price date Conversion rights instrument rights (xix, (xvii) period refers to xx) (xviii) ------------------ --------- ----------- ------------ ------------------- ---------------- Nominal Delta ------------------ --------- ----------- ------------ ------------------- -------- ------ Total (A+B+C) ------------------------------------------------------ Number of voting rights Percentage of voting rights ------------------------ ---------------------------- 8,460,451 4.05% ------------------------ ---------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) --------------------------------------------------------------- The voting rights are managed and controlled by Aviva Investors Global Services Limited and Friends Provident International Limited, with the following chain of controlled undertakings:- Aviva Investors Global Services Limited: * Aviva plc (Parent Company) * Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc) * Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Limited) * Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited) Friends Provident International Limited: * Aviva plc (Parent Company) * Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc) * Aviva Life Holdings UK Limited (wholly owned subsidiary of Aviva Group Holdings Limited) * Friends Life FPG Limited (wholly owned subsidiary of Aviva Life Holdings UK Limited) * Friends Life FPL Limited (wholly owned subsidiary of Friends Life FPG Limited) * Friends Life Limited (wholly owned subsidiary of Friends Life FPL Limited) * Friends Life and Pensions Limited (wholly owned subsidiary of Friends Life Limited) * Friends Provident International Limited (wholly owned subsidiary of Friends Life and Pensions Limited) --------------------------------------------------------------- Proxy Voting: ------------------------------------------------------------------------- 10. Name of the proxy holder: See Section 4 ------------------------------------- ----------------------------------
(MORE TO FOLLOW) Dow Jones Newswires
March 30, 2016 12:08 ET (16:08 GMT)
11. Number of voting rights proxy holder will cease to hold: ------------------------------------- ---------------------------------- 12. Date on which proxy holder will cease to hold voting rights: ------------------------------------- ---------------------------------- 13. Additional information: Figures are based on a total number of voting rights of 209,022,716 as per the Company's Total Voting Rights Announcement of 31 December 2015. ------------------------------------- ---------------------------------- 14. Contact name: Michael Dunhill, Aviva plc ------------------------------------- ---------------------------------- 15. Contact telephone number: 01603 685988 ------------------------------------- ----------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLURRNRNVAOOAR
(END) Dow Jones Newswires
March 30, 2016 12:08 ET (16:08 GMT)
1 Year Advanced Medical Solutions Chart |
1 Month Advanced Medical Solutions Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions